16-033
Showing 1 - 25 of 6,109
Chronic Hand Eczema Trial in Canada, Spain, United Kingdom (Delgocitinib, Cream vehicle)
Recruiting
- Chronic Hand Eczema
- Delgocitinib
- Cream vehicle
-
Darlinghurst, Australia
- +25 more
Dec 12, 2022
Atopic Dermatitis Trial in Germany, Poland (Lebrikizumab)
Recruiting
- Atopic Dermatitis
- Lebrikizumab
-
Darmstadt, Hessen, Germany
- +31 more
Jun 21, 2023
Atopic Dermatitis Trial in Worldwide (LEO 152020 tablet, LEO 152020 tablet)
Recruiting
- Atopic Dermatitis
- LEO 152020 tablet
- LEO 152020 placebo tablet
-
Beverly Hills, California
- +41 more
Feb 1, 2023
SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza
Active, not recruiting
- SARS-CoV-2 Infection
- COVID-19
- SARS-CoV-2 rS/Matrix M1-Adjuvant
- +2 more
-
Belfast, Antrim, United Kingdom
- +32 more
Oct 19, 2022
Chronic Hand Eczema Trial in Worldwide (Delgocitinib cream, Cream vehicle)
Completed
- Chronic Hand Eczema
- Delgocitinib cream
- Cream vehicle
-
Calgary, Alberta, Canada
- +53 more
Nov 1, 2022
Atopic Dermatitis Trial in Worldwide (Benralizumab, Placebo / Benralizumab)
Terminated
- Atopic Dermatitis
- Benralizumab
- Placebo / Benralizumab
-
Los Angeles, California
- +50 more
Jan 4, 2023
Advanced Malignant Tumors Trial in China (LBL-033 for Injection)
Not yet recruiting
- Advanced Malignant Tumors
- LBL-033 for Injection
-
Fuzhou, Fujian, China
- +5 more
Mar 19, 2023
NSCLC Trial (Pembrolizumab, Docetaxel)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Pembrolizumab
- Docetaxel
- (no location specified)
Aug 18, 2022
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
Atopic Dermatitis Trial in Worldwide (LEO 138559, LEO 138559 )
Completed
- Atopic Dermatitis
- LEO 138559
- LEO 138559 placebo
-
Birmingham, Alabama
- +16 more
Oct 20, 2022
Active Psoriatic Arthritis Trial in Worldwide (TILD, matching injections)
Recruiting
- Active Psoriatic Arthritis
- TILD
- matching placebo injections
-
Anniston, Alabama
- +95 more
Dec 5, 2022
Second-trimester TOP :Retrospective Study Comparing
Completed
- Abortion in First Trimester
- Abortion, Second Trimester
- (no location specified)
Jul 20, 2022
Patients With Advanced Solid Tumors Trial in Sichuan (ICP-033 tablet)
Recruiting
- Patients With Advanced Solid Tumors
- ICP-033 tablet
-
Sichuan, Chengdu, ChinaWest China Hospital of Sichuan University
Nov 28, 2022
NSCLC, EGFR-mutant Lung Cancers Trial in United States (osimertinib, Bevacizumab)
Completed
- Non-small Cell Lung Cancer
- EGFR-mutant Lung Cancers
-
Basking Ridge, New Jersey
- +6 more
Mar 2, 2022
Psychosis Associated With Alzheimer's Disease Trial in Lafayette (KarXT)
Enrolling by invitation
- Psychosis Associated With Alzheimer's Disease
-
Lafayette, CaliforniaClinical Trial Site
Jul 31, 2023
Healthy Volunteers Trial in Secaucus (NRS-033, Placebo)
Not yet recruiting
- Healthy Volunteers
- NRS-033
- Placebo
-
Secaucus, New JerseyFrontage Clinical Research Center
Feb 10, 2023
The Experiences of Patients In Schizophrenia Research
Not yet recruiting
- Schizophrenia
- (no location specified)
May 12, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
CMV* Reactivation and Anti-cytokine Treatment in Critical
Completed
- COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
- CMV DNA analysis
-
Istanbul, TurkeyHisar Hospital Intercontinental
Jun 13, 2022
Chronic Low-back Pain, Older Adults, Core Stabilization Exercise Therapy Trial in Hong Kong (core stabilization exercise)
Recruiting
- Chronic Low-back Pain
- +2 more
- core stabilization exercise
-
Hong Kong, Hong KongThe Hong Kong Polytechnic University
Sep 6, 2023